Steve Hoffmaster
About Steve Hoffmaster
Steve Hoffmaster is the Director of Sales Planning and Reporting at Alkermes in the Greater Boston Area, with a strong background in sales analytics and commercial operations.
Title
Steve Hoffmaster holds the position of Director, Sales Planning and Reporting at Alkermes, based in the Greater Boston Area. In this role, he manages the strategic planning and reporting for sales activities within the organization.
Current Company
Steve Hoffmaster currently works at Alkermes, a biopharmaceutical company that focuses on central nervous system (CNS) diseases. He serves as the Director of Sales Planning and Reporting, where he oversees sales performance metrics and analytics to aid in commercial operations.
Previous Roles
Steve Hoffmaster has a robust professional background with numerous roles in various companies. Notably, he worked at Alkermes as Associate Director, Field Measurement for eight months between 2017 and 2018. Prior to this, he spent five years at EMD Serono, Inc. as Senior Manager, Sales Analytics. He has also held roles at Molecular Response and Ferring Pharmaceuticals in business development, laboratory supervision, and research. His extensive experience has largely been centered in the Greater Boston and San Diego areas.
Education and Expertise
Steve Hoffmaster has a diverse educational background. He earned an M.B.A. in Finance from San Diego State University from 2005 to 2008. Additionally, he achieved a Professional Certificate in Drug Discovery and Development from the University of California, San Diego Extension between 2001 and 2003. Lastly, he holds a B.S. in Molecular Biology from UC San Diego, which he earned in 1999. His expertise spans finance, drug discovery, CNS disease therapy, and performance metrics.
Professional Interests
Steve Hoffmaster has a strong professional interest in analytics and commercial operations. His focus on CNS disease therapy is a central theme across his roles and responsibilities. His expertise in performance metrics aligns with his current role at Alkermes, where he contributes to sales planning and reporting.